- Home
- TTAN vs CORT Comparison
TTAN vs CORT Comparison
Compare TTAN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTAN
- CORT
- Stock Information
- Founded
- TTAN 2012
- CORT 1998
- Country
- TTAN United States
- CORT United States
- Employees
- TTAN N/A
- CORT N/A
- Industry
- TTAN
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- TTAN
- CORT Health Care
- Exchange
- TTAN NYSE
- CORT Nasdaq
- Market Cap
- TTAN 8.4B
- CORT 7.1B
- IPO Year
- TTAN 2024
- CORT N/A
- Fundamental
- Price
- TTAN $124.22
- CORT $70.23
- Analyst Decision
- TTAN Buy
- CORT Strong Buy
- Analyst Count
- TTAN 14
- CORT 4
- Target Price
- TTAN $118.23
- CORT $142.00
- AVG Volume (30 Days)
- TTAN 458.9K
- CORT 1.4M
- Earning Date
- TTAN 06-05-2025
- CORT 05-05-2025
- Dividend Yield
- TTAN N/A
- CORT N/A
- EPS Growth
- TTAN N/A
- CORT 8.36
- EPS
- TTAN N/A
- CORT 1.14
- Revenue
- TTAN $771,878,000.00
- CORT $685,446,000.00
- Revenue This Year
- TTAN $19.04
- CORT $36.81
- Revenue Next Year
- TTAN $13.40
- CORT $32.00
- P/E Ratio
- TTAN N/A
- CORT $61.85
- Revenue Growth
- TTAN 25.64
- CORT 30.93
- 52 Week Low
- TTAN $79.81
- CORT $25.35
- 52 Week High
- TTAN $128.16
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- TTAN N/A
- CORT 50.58
- Support Level
- TTAN N/A
- CORT $68.92
- Resistance Level
- TTAN N/A
- CORT $75.41
- Average True Range (ATR)
- TTAN 0.00
- CORT 3.76
- MACD
- TTAN 0.00
- CORT -0.19
- Stochastic Oscillator
- TTAN 0.00
- CORT 57.96
About TTAN SERVICETITAN INC
ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.